The artemisinic acid market size was estimated at US$ 699.2 million in 2022 it is predicted to grow at a CAGR of 4.26% from 2023 to 2032 to reach around US$ 1,061.15 million by the end of 2032.
The artemisinic acid market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global artemisinic acid market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global artemisinic acid market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40216
Report Scope of the Artemisinic Acid Market
| Report Coverage | Details |
| Market Size in 2022 | USD 699.2 million |
| Revenue Forecast by 2032 | USD 1,061.15 million |
| Growth rate from 2023 to 2032 | CAGR of 4.26% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Sanofi; KPC Pharmaceuticals, Inc.; Guilin Pharmaceutical Co., Ltd; Calyx Chemicals and Pharmaceuticals Ltd.; Novartis AG; Ipca Laboratories Ltd.; Cipla Inc.; Shin Poong Pharm Co., Ltd.; Rupus Global Limited; AdvacarePharma |
This study covers an elaborate segmentation of the global artemisinic acid market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global artemisinic acid market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Market Segmentation
By Type
- Antimalarial Injections
- Antimalarial Tablets
By Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- South Korea
- Thailand
- Australia
- Pakistan
- Indonesia
- Vietnam
- Central & South America
- Mexico
- Argentina
- Colombia
- Brazil
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Nigeria
- Democratic Republic of Congo
- Mali
- Uganda
- Kenya
Research Methodology
The research methodology acquire by analysts for assemble the global artemisinic acid market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global artemisinic acid market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2. Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3. Executive Summary
3.1.Market Snapshot
Chapter 4. Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on Artemisinic Acid Market
5.1. COVID-19 Landscape: Artemisinic Acid Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. Global Artemisinic Acid Market, By Type
8.1.Artemisinic Acid Market, by Type Type, 2023-2032
8.1.1. Antimalarial Injections
8.1.1.1.Market Revenue and Forecast (2020-2032)
8.1.2. Antimalarial Tablets
8.1.2.1.Market Revenue and Forecast (2020-2032)
Chapter 9. Global Artemisinic Acid Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Type (2020-2032)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Type (2020-2032)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Type (2020-2032)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Type (2020-2032)
Chapter 10.Company Profiles
10.1. Sanofi
10.1.1.Company Overview
10.1.2.Product Offerings
10.1.3.Financial Performance
10.1.4.Recent Initiatives
10.2. KPC Pharmaceuticals, Inc.
10.2.1.Company Overview
10.2.2.Product Offerings
10.2.3.Financial Performance
10.2.4.Recent Initiatives
10.3. Guilin Pharmaceutical Co., Ltd
10.3.1.Company Overview
10.3.2.Product Offerings
10.3.3.Financial Performance
10.3.4.Recent Initiatives
10.4. Calyx Chemicals and Pharmaceuticals Ltd.
10.4.1.Company Overview
10.4.2.Product Offerings
10.4.3.Financial Performance
10.4.4.Recent Initiatives
10.5. Novartis AG
10.5.1.Company Overview
10.5.2.Product Offerings
10.5.3.Financial Performance
10.5.4.Recent Initiatives
10.6. Ipca Laboratories Ltd.
10.6.1.Company Overview
10.6.2.Product Offerings
10.6.3.Financial Performance
10.6.4.Recent Initiatives
10.7. Cipla Inc.
10.7.1.Company Overview
10.7.2.Product Offerings
10.7.3.Financial Performance
10.7.4.Recent Initiatives
10.8. Shin Poong Pharm Co., Ltd.
10.8.1.Company Overview
10.8.2.Product Offerings
10.8.3.Financial Performance
10.8.4.Recent Initiatives
10.9. Rupus Global Limited
10.9.1.Company Overview
10.9.2.Product Offerings
10.9.3.Financial Performance
10.9.4.Recent Initiatives
10.10. AdvacarePharma
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11.Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12.Appendix
12.1. About Us
12.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168